Not FDA-approved1,4Evidence: Animal and lab onlyBrain, nerves and sleep

Humanin1,2

Key takeaway

Humanin is a 24-amino-acid peptide that researchers identified in 2001 while searching for genes that protect nerve cells from damage linked to Alzheimer disease.1,2 Its evidence comes from laboratory studies: it protected cultured nerve cells from death caused by Alzheimer disease genes and amyloid beta.2,3 No study of humanin given to people and no FDA approval are reported in the sources reviewed here, and it is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.2,4,6

Humanin at a glance

What it isA 24-amino-acid peptide (MAPRGFSCLLLLTSEIDLPVKRRA), according to FDA’s substance registry.1
FDA statusNo FDA approval is reported in the sources reviewed here. FDA’s compounding safety-risk page does not list it.1,4
Human evidenceNone found: the studies reviewed here used cultured cells.2,3
Evidence strengthAnimal and lab studies only. The cited sources report no completed human study; the research base consists of animal, cell, or other laboratory work. How this label is assigned

What is humanin?

Humanin is a peptide of 24 amino acids. FDA’s substance registry records its sequence as MAPRGFSCLLLLTSEIDLPVKRRA.1

Researchers found the gene for it in 2001 by screening for genes that rescue nerve cells, and named it humanin. Cells given the gene made the peptide and released it.2

How is humanin thought to work?

In cultured nerve cells it prevented death caused by several familial Alzheimer disease genes and by amyloid beta, but not by some other causes, and the effect depended on its exact sequence, according to the 2001 report.2

A 2003 study found that it binds insulin-like growth factor-binding protein 3 tightly and, in one human brain-tumour cell line, blocked the cell death that protein can trigger.3

What do human studies show?

None of the sources reviewed here describes a study in which humanin was given to people.2,3

The 2001 researchers proposed it as a lead for developing Alzheimer disease treatments; that remains a hypothesis in the sources reviewed here.2

What the evidence base contains

  • Animal or laboratory research Cell studies in which humanin, made from a gene found through screening, blocked nerve-cell death caused by several familial Alzheimer disease genes and by amyloid beta.2
  • Animal or laboratory research Cell studies showing that humanin binds insulin-like growth factor-binding protein 3 and, in one human brain-tumour cell line, blocks the cell death that protein triggers.3

Evidence-strength label: Animal and lab studies only. How this label is assigned

Is humanin FDA-approved?

None of the sources reviewed here reports an approval of humanin by FDA.1,4

FDA’s compounding safety-risk page, current as of April 22, 2026, does not list humanin.4

HHS’s October 30, 2026 draft enforcement-discretion policy lists six peptides in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. Humanin is not among them.5,6

Timeline

  1. Researchers report identifying humanin as a factor that rescues nerve cells from Alzheimer disease-related death.2
  2. A study reports that humanin binds insulin-like growth factor-binding protein 3.3

What is still unknown?

Whether it has any effect, or is safe, when given to people: the studies reviewed here are laboratory studies.2,3

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Go deeper

Records, reviews and history

Everything PeptideScanner has collected for Humanin: reviews, official-source readings, registry and literature records, and every change to this profile.

What the trial and literature lists cover. The trials and papers listed for Humanin are a bounded selection, not every registration or paper about Humanin. For the years before Humanin was added, PeptideScanner took at most 25 ClinicalTrials.gov registrations that list Humanin as an intervention: trials with posted results first, then later-phase trials, then the most recently updated. It also took at most 25 PubMed papers that name Humanin in the title: randomized controlled trials, clinical trials, meta-analyses, systematic reviews and reviews first, then the most recent. Records that also named another tracked peptide, or that failed the publication checks, were left out. A daily check adds newly updated registrations and newly indexed papers that pass the same checks. How records are selected.

Status brief and reviewed-evidence summary

Evidence summary

What the cited records show

What is its status in the cited records?

No FDA approval reported; studied only in the laboratory. Evidence comes from cell studies. Humanin is not on FDA’s compounding safety-risk page and is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗

Status sources checked through November 14, 2026. See status sources and coverage →

Research records

Explore this profile’s cited source records →

An editorial human-evidence summary has not yet been published.

Explore status sources, recent additions, and coverage gaps

Living status brief

What is the current status of Humanin?

No FDA approval reported; studied only in the laboratory. Evidence comes from cell studies. Humanin is not on FDA’s compounding safety-risk page and is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗

The cited status sources were checked through November 14, 2026. This answer changes only through the profile’s visible version and correction history.

Evidence present

What records are connected here?

Evidence lanes
1
Source years
8
Drugs@FDA applications
0

These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.

Collection changes

What did PeptideScanner add most recently?

  1. Literature metadata · added November 16, 2026

    Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile.↗Source date November 9, 2026
  2. Literature metadata · added November 16, 2026

    Mitochondrial-derived peptides and cytoprotection in acute respiratory distress syndrome: emerging therapeutic promise of humanin.↗Source date October 30, 2026
  3. Literature metadata · added November 16, 2026

    Network Topology and Interactomic Analysis Reveal the Regulatory Framework of the Humanin Protein Family (MTRNR2Lx Class).↗Source date August 13, 2026

Coverage gaps

What remains unknown or unsupported?

PeptideScanner currently has no selected clinical trial records, regulatory records, and safety records connected to this profile. That is a collection gap, not evidence that no such records exist.

PeptideScanner does not infer an answer where the cited records do not provide one. Open the source-linked records below to inspect their scope and limits.

Explore the Evidence Map and record counts

Evidence Map v1

What kinds of records connect to Humanin?

Compare collection coverage →

This map describes PeptideScanner’s selected, source-linked collection. It is not an evidence grade and does not establish research quality, safety, effectiveness, or medical relevance.

25Selected dated records
31Connected citations
8Populated source years2011–2026
1/4Record lanes present

Registered human studies

Trial composition

0 of 0 selected trial records include at least one phase value; 0 of 0 include a status value in the retained structured contract.

PubMed bibliography

Publication composition

25 of 25 selected PubMed records include attributed title, venue, publication date, and publication-type fields.

Publication typesJournal Article 24Review 17Research Support, Non-U.S. Gov't 9Research Support, N.I.H., Extramural 2Comment 1Editorial 1Research Support, N.I.H., Intramural 1

Regulatory and publication surfaces

What is structurally connected?

Drugs@FDA applications
0
FDA Federal Register documents
0
DailyMed SPL versions
0
Canonical profile
Published
Profile structured data
Published
Linked dated records
25

Application counts reflect exact reviewed ingredient connections; Federal Register counts reflect exact reviewed peptide-name matches; DailyMed counts reflect listed SPL versions with retained ZIP receipts. “Published” describes this page’s indexing surface, not the state of scientific evidence.

Profile publication history and record counts
Source records by collection · 25 dated records

Research hub

Explore the Humanin evidence record

Open all 25 records →
25Dated records
1Evidence type
25Cited public sources
8Source years

Change ledger

Recently changed for Humanin

Open all 25 events →

PeptideScanner change dates and cited source dates stay separate. These entries report collection or version activity, not a ranking of importance.

Record added

Unravelling the role of Humanin.

PubMed lists PMID 15106598 in Trends in molecular medicine as Journal Article, Review, with publication-date metadata of 2004-03 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 8, 2019
Evidence lane
Literature metadata
Record added

Humanin: after the discovery.

PubMed lists PMID 15655255 in Molecular neurobiology as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 13, 2018
Evidence lane
Literature metadata
Record added

Humanin; a defender against Alzheimer's disease?

PubMed lists PMID 19149712 in Recent patents on CNS drug discovery as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-01 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 11, 2019
Evidence lane
Literature metadata

Official-source collections

Source records for Humanin

Open the full research atlas →

Evidence types

Coverage by source year

Selected records span April 28, 2011 to November 9, 2026. These dates come from selected source records and PubMed metadata, not a complete or continuous timeline of research, safety, approval, or effectiveness.

Continue exploring

Profiles with overlapping source-year coverage

Open the research atlas →

These links are based only on overlapping years and evidence lanes in PeptideScanner’s selected records. They do not imply that the peptides are medically or scientifically similar.

Organizations and trial records named in cited sources

Organizations named in cited records

  • U.S. Food and Drug Administration1,4
  • U.S. Department of Health and Human Services5
Dated updates connected to this profile · 25

Updates connected to this profile

Open the full cross-source timeline →
  1. Literature metadata

    Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile.↗

    PubMed lists PMID 41186863 in Journal of endocrinological investigation as Journal Article, with publication-date metadata of 2025-11-04 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Mitochondrial-derived peptides and cytoprotection in acute respiratory distress syndrome: emerging therapeutic promise of humanin.↗

    PubMed lists PMID 42262906 in American journal of respiratory cell and molecular biology as Editorial, Comment, with publication-date metadata of 2026-11-01 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Network Topology and Interactomic Analysis Reveal the Regulatory Framework of the Humanin Protein Family (MTRNR2Lx Class).↗

    PubMed lists PMID 42509775 in Biomolecules as Journal Article, with publication-date metadata of 2026-07-03 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Humanin as a Molecular Indicator of Semen Quality and Cryotolerance in Crossbred Cattle.↗

    PubMed lists PMID 42223320 in Reproduction in domestic animals = Zuchthygiene as Journal Article, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Humanin as an evolutionarily tuned mitochondrial peptide: Insights from mammalian oxidative stress diversity.↗

    PubMed lists PMID 41864362 in Free radical biology & medicine as Journal Article, with publication-date metadata of 2026-03-20 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    [Humanin: a mitochondria-hidden peptide serving inflammation resolution].↗

    PubMed lists PMID 42028934 in Medecine sciences : M/S as Journal Article, with publication-date metadata of 2026-04-24 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Humanin variants aggregate to produce different fibril morphologies.↗

    PubMed lists PMID 40543583 in The Journal of biological chemistry as Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    Detection of Mitochondrial-Derived Peptide Humanin in Semen and Reproductive Tract of Caprine Along With Its Relation to Seasonality.↗

    PubMed lists PMID 40838645 in Reproduction in domestic animals = Zuchthygiene as Journal Article, with publication-date metadata of 2025-08 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  9. Literature metadata

    Humanin and Its Pathophysiological Roles in Aging: A Systematic Review.↗

    PubMed lists PMID 37106758 in Biology as Journal Article, Review, with publication-date metadata of 2023-04-06 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  10. Literature metadata

    Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition.↗

    PubMed lists PMID 35104624 in Biochimica et biophysica acta. General subjects as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2022-01-31 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Literature metadata

    Humanin and diabetes mellitus: A review of in vitro and in vivo studies.↗

    PubMed lists PMID 35432758 in World journal of diabetes as Journal Article, Review, with publication-date metadata of 2022-03-15 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  12. Literature metadata

    The Molecular Structure and Role of Humanin in Neural and Skeletal Diseases, and in Tissue Regeneration.↗

    PubMed lists PMID 35372353 in Frontiers in cell and developmental biology as Journal Article, Review, with publication-date metadata of 2022-03-16 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    Humanin substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  2. 2
    A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Abeta (2001) · PMID 11371646 ↗

    Proceedings of the National Academy of Sciences of the United States of America · Official source · Source checked November 16, 2026

  3. 3
    Interaction between the Alzheimer’s survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis (2003) · PMID 14561895 ↗

    Proceedings of the National Academy of Sciences of the United States of America · Official source · Source checked November 16, 2026

  4. 4
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  5. 5
    Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances · notice of availability · 91 FR 68526 · October 30, 2026 ↗

    Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026

  6. 6
    HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendix A (list of peptides) and Appendix B (identities and justifications) ↗

    U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026